Equity Overview
Price & Market Data
Price: $6.53
Daily Change: -$0.17 / 2.60%
Range: $6.15 - $7.20
Market Cap: $286,609,536
Volume: 43,019
Performance Metrics
1 Week: -1.21%
1 Month: -12.64%
3 Months: 31.75%
6 Months: 31.75%
1 Year: 31.75%
YTD: 13.17%
Details
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.